Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of CCI-779 (NSC 683864) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumours

NCT00408655 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00408655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00408655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of CCI-779 (NSC 683864) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumours
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2007
Completion date
Not reported
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian sarcoma, ovarian stromal cancer, recurrent endometrial carcinoma, recurrent ovarian epithelial cancer, recurrent ovarian germ cell tumor, stage iii endometrial carcinoma, stage iii ovarian epithelial cancer, stage iii ovarian germ cell tumor, stage iv endometrial carcinoma, stage iv ovarian epithelial cancer, stage iv ovarian germ cell tumor, unspecified adult solid tumor, protocol specific